Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pumaprazole (BY-841) is an antagonist of a reversible proton pump.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 247.00 | |
5 mg | In stock | $ 572.00 | |
10 mg | In stock | $ 788.00 | |
25 mg | In stock | $ 1,580.00 | |
50 mg | In stock | $ 2,160.00 | |
100 mg | In stock | $ 2,890.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 578.00 |
Description | Pumaprazole (BY-841) is an antagonist of a reversible proton pump. |
In vivo | Pumaprazole shows identical ID50 values on day 1 (11 μmol/kg, 95% confidence limits of 5 and 23), and on day 7 (10 μmol/kg, 95% confidence limits of 4 and 23) of a repeated dose study in this model. Basal acid secretion in the Ghosh-Schild rat is inhibited by Pumaprazole with a higher efficacy compared to ranitidine. The lower dose of Pumaprazole (27 μmol/kg) rapidly elevates luminal pH up to almost neutrality, the higher dose (54 μmol/kg) further prolongs this pH-elevating effect[1]. |
Synonyms | BY-841 |
Molecular Weight | 338.4 |
Formula | C19H22N4O2 |
CAS No. | 158364-59-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/ml (162.53 mM), Sonification is recommended
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pumaprazole 158364-59-1 Membrane transporter/Ion channel Proton pump inhibit Proton Pump BY-841 BY841 BY 841 Inhibitor inhibitor